Literature DB >> 3083446

The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma.

H Friedman, D R Abernethy, D J Greenblatt, R I Shader.   

Abstract

The pharmacokinetics of diazepam (DZ) and its major metabolite desmethyldiazepam (DMDZ) in both plasma and brain after a single 5 mg/kg IP dose of diazepam were studied in rats. Four rats were sacrificed at 5 min, 15 min, 30 min, 1 h, 1.5, 2, 3, 4, 5 and 6 h after the dose. DZ rapidly disappeared from plasma and brain in parallel, with nearly identical overall half-lives of 0.88 and 0.89 h, respectively. Apparent volume of distribution was 19.3 1/kg and the apparent total clearance was 255 ml/kg/min. Free fractions were 19.6% and 15.8% for DZ and DMDZ, respectively. DMDZ rapidly appeared in both plasma and brain. Thereafter, DMDZ was likewise eliminated in parallel from both compartments, with nearly identical half-lives of disappearance from plasma (1.11 h) and brain (1.09 h). The rapid elimination of DZ was due to its very high clearance. Brain to plasma concentration ratios did not differ significantly over time either for DZ or for DMDZ. The overall ratios (mean +/- SE) were 4.5 +/- 0.1 for DZ and 3.5 +/- 0.2 for DMDZ. Equilibrium was attained at no more than 5 min after dose for both DZ and DMDZ. No evidence was found for persistence or sequestration of DZ or DMDZ in brain longer than could be predicted on the basis of first-order exponential disappearance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083446     DOI: 10.1007/bf00180822

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Letter: Concentrations of diazepam in adipose tissue of children.

Authors:  J H Kanto; K K Pihlajamaki; E U Iisalo
Journal:  Br J Anaesth       Date:  1974-02       Impact factor: 9.166

2.  Kinetics of distribution and metabolism of diazepam and chlordiazepoxide in mice.

Authors:  E van der Kleijn
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-03

3.  Levels of diazepam in adipose tissue of rats, mice and man.

Authors:  F Marcucci; R Fanelli; M Frova; P L Morselli
Journal:  Eur J Pharmacol       Date:  1968-11       Impact factor: 4.432

Review 4.  Drug therapy. Current status of benzodiazepines.

Authors:  D J Greenblatt; R I Shader; D R Abernethy
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

Review 5.  Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

6.  Brain uptake of phenytoin, phenobarbital, and diazepam.

Authors:  R E Ramsay; E J Hammond; R J Perchalski; B J Wilder
Journal:  Arch Neurol       Date:  1979-09

7.  Effect of age on levels of diazepam in plasma and brain of rats.

Authors:  U Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

8.  Correlation between benzodiazepine receptor occupation and anticonvulsant effects of diazepam.

Authors:  S M Paul; P J Syapin; B A Paugh; V Moncada; P Skolnick
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  Diazepam disposition in mature and aged rabbits and rats.

Authors:  C F Tsang; G R Wilkinson
Journal:  Drug Metab Dispos       Date:  1982 Jul-Aug       Impact factor: 3.922

10.  A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines.

Authors:  M L Jack; W A Colburn; N M Spirt; G Bautz; M Zanko; W D Horst; R A O'Brien
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

View more
  18 in total

1.  Behavioral and brain temperature responses to salient environmental stimuli and intravenous cocaine in rats: effects of diazepam.

Authors:  Eugene A Kiyatkin; David Bae
Journal:  Psychopharmacology (Berl)       Date:  2007-10-16       Impact factor: 4.530

Review 2.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Distribution of diazepam, nordiazepam, and oxazepam between brain extraneuronal space, brain tissue, plasma, and cerebrospinal fluid in diazepam and nordiazepam dependent dogs.

Authors:  E P Wala; W R Martin; J W Sloan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Stability and pharmacokinetics of flumazenil in the rat.

Authors:  J W Mandema; J M Gubbens-Stibbe; M Danhof
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Status epilepticus: Role for etiology in determining response to benzodiazepines.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Kyle M Hawk; Stephen J Chester; Howard P Goodkin
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

6.  Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism.

Authors:  M L Vargas; C Abella; J Hernandez
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Diazepam Inhibits Post-Traumatic Neurogenesis and Blocks Aberrant Dendritic Development.

Authors:  Laura E Villasana; Austin Peters; Raluca McCallum; Chang Liu; Eric Schnell
Journal:  J Neurotrauma       Date:  2019-05-06       Impact factor: 5.269

8.  Insights into functional pharmacology of α₁ GABA(A) receptors: how much does partial activation at the benzodiazepine site matter?

Authors:  Srđan Joksimović; Zdravko Varagic; Jovana Kovačević; Michael Van Linn; Marija Milić; Sundari Rallapalli; Tamara Timić; Werner Sieghart; James M Cook; Miroslav M Savić
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

9.  Changes in benzodiazepine-GABA receptor coupling in an accumbens-habenula circuit after chronic diazepam treatment.

Authors:  R R Brett; J A Pratt
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Nuclear benzodiazepine binding: possible interaction with thyroid hormone receptors.

Authors:  Y Dalezios; N Matsokis
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.